Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem ... Aug 11
The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. ... Aug 08
Dr. Jogin Desai, CEO, Eyestem, expressed hope that CCMB will be able to leverage its platform and advance COVID-19 research that will help the ... May 06
-Advertisements-